NURO
$2.35
Neurometrix
($.20)
(7.84%)
NURO
Earnings Whisper ®
N/A
1st Quarter March 2020
Consensus:  $0.00
Revenue:  N/A
Monday
Jan 27
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when NURO reports earnings?
Beat
Meet
Miss

Where is NURO's stock price going from here?
Up
Flat
Down
Stock chart of NURO
Analysts
Summary of analysts' recommendations for NURO
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders.
Peers
StrykerBoston ScientificBecton, DickinsonWatersAbbott LaboratoriesBaxter InternationalTeleflex3MIntegra LifeSciences HoldingsMerit Medical Systems